Medicines indicated for the treatment of peptic ulcer and GERD are H2 blockers, proton pump inhibitors, antacids and mucoprotective agents. The analysis of the market of the medicines used for treatment of peptic ulcer and GERD, implies analysis of the range of these medicines registered in RNM, their presence on the list of medicines which costs are covered by the Health Insurance Fund, their financial and physical availability, as opposed to treatment recommendations of the above conditions according to MBD as well as a comparison of the range of these drugs available on the world markets. For the analysis of the consumptions of drugs issued at the expense of the Health Insurance Fund in pharmacies of the Republic of North Macedonia for a period of four years by number of realized prescriptions and total amounts of funds, we used the data published on the official website of the Health Insurance Fund of RNM. The increase in the total number of prescription drugs is probably due to the large number of patients diagnosed with peptic ulcer and GERD, as well as the recent regimen for issuing such medicines without a prescription. The total amounts for issued medicines at the expense of the Health Insurance Fund depend on the price and the number of issued prescriptions. The RNM is a county with a low standard and limited budget for medicine, in which the health policies are oriented towards saving the funds for procurement of drugs.
Key words: registered drugs, blockers, proton pump inhibitors, treatment
|
